Please use this identifier to cite or link to this item:
Title: Impact of dose and surface features on plasmatic and liver concentrations of biodegradable polymeric nanocapsules.
Authors: Oliveira, Líliam Teixeira
Paula, Mônica Auxiliadora de
Roatt, Bruno Mendes
Garcia, Giani Martins
Silva, Luan Silvestro Bianchini
Reis, Alexandre Barbosa
Paula, Carina Silva de
Vilela, José Mário Carneiro
Andrade, Margareth Spangler
Lana, Gwenaelle Elza Nathalie Pound
Mosqueira, Vanessa Carla Furtado
Keywords: Chitosan
Polymer dose
Field flow fractionation
Issue Date: 2017
Citation: OLIVEIRA, L. T. et al. Impact of dose and surface features on plasmatic and liver concentrations of biodegradable polymeric nanocapsules. European Journal Of Pharmaceutical Sciences, v. 105, p. 19-32, 2017. Disponível em: <>. Acesso em: 29 ago. 2017.
Abstract: The effect of polymeric nanocapsule dose on plasmatic and liver concentrations 20 min after intravenous administration in mice was evaluated. Nanocapsules were prepared with different polymers, namely, poly(D,Llactide) (PLA), polyethylene glycol-block-poly(D,L-lactide) (PLA-PEG), and PLA with chitosan (PLA-Cs) and compared with a nanoemulsion. These formulations were labelled with a phthalocyanine dye for fluorescent detection. The nanostructures had narrow size distributions upon separation by asymmetric flow field flow fractionation with static and dynamic light scattering detection, with average hydrodynamic diameters in the 130–300 nm range, negative zeta potentials, except PLA-Cs nanocapsules, which had a positive zeta potential. Flow cytometry revealed uptake mostly by monocytes and neutrophils in mice and human blood. PLA nanocapsules and the nanoemulsion showed dose-dependent plasma concentrations, where the percentage of plasmatic fluorescence increased with increasing administered dose. In contrast, PLA-PEG nanocapsules led to a dose-independent plasmatic profile. PLA-Cs nanocapsules showed the lowest plasmatic and liver levels of fluorescence at all administered doses and significant intravenous toxicity in mice. This work demonstrates the importance of considering the nanocarrier dose when evaluating pharmacokinetic and biodistribution data and emphasizes the role of surface features in determining the plasmatic and liver concentrations of a poorly soluble lipophilic encapsulated compound.
ISSN:  0928-0987
metadata.dc.rights.license: O Periódico European Journal of Pharmaceutical Sciences concede permissão para depósito deste artigo no Repositório Institucional da UFOP. Número da licença: 4178330424505.
Appears in Collections:DEACL - Artigos publicados em periódicos

Files in This Item:
File Description SizeFormat 
ARTIGO_ImpactDoseSurface.pdf1,21 MBAdobe PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.